Effects and treatment methods of acupuncture and herbal medicine for premenstrual syndrome/premenstrual dysphoric disorder: systematic review

Su Hee Jang, Dong Il Kim, Min-Sun Choi, Su Hee Jang, Dong Il Kim, Min-Sun Choi

Abstract

Background: During their reproductive years about 10% of women experience some kind of symptoms before menstruation (PMS) in a degree that affects their quality of life (QOL). Acupuncture and herbal medicine has been a recent favorable therapeutic approach. Thus we aimed to review the effects of acupuncture and herbal medicine in the past decade as a preceding research in order to further investigate the most effective Korean Medicine treatment for PMS/PMDD.

Methods: A systematic literature search was conducted using electronic databases on studies published between 2002 and 2012. Our review included randomized controlled clinical trials (RCTs) of acupuncture and herbal medicine for PMS/PMDD. Interventions include acupuncture or herbal medicine. Clinical information including statistical tests was extracted from the articles and summarized in tabular form or in the text. Study outcomes were presented as the rate of improvement (%) and/or end-of-treatment scores.

Results: The search yielded 19 studies. In screening the RCTs, 8 studies in acupuncture and 11 studies in herbal medicine that matched the criteria were identified. Different acupuncture techniques including traditional acupuncture, hand acupuncture and moxibustion, and traditional acupuncture technique with auricular points, have been selected for analysis. In herbal medicine, studies on Vitex Agnus castus, Hypericum perforatum, Xiao yao san, Elsholtzia splendens, Cirsium japonicum, and Gingko biloba L. were identified. Experimental groups with Acupuncture and herbal medicine treatment (all herbal medicine except Cirsium japonicum) had significantly improved results regarding PMS/PMDD.

Conclusions: Limited evidence supports the efficacy of alternative medicinal interventions such as acupuncture and herbal medicine in controlling premenstrual syndrome and premenstrual dysphoric disorder. Acupuncture and herbal medicine treatments for premenstrual syndrome and premenstrual dysphoric disorder showed a 50% or better reduction of symptoms compared to the initial state. In both acupuncture and herbal medical interventions, there have been no serious adverse events reported, proving the safety of the interventions while most of the interventions provided over 50% relief of symptoms associated with PMS/PMDD. Stricter diagnostic criteria may have excluded many participants from some studies. Also, depending on the severity of symptoms, the rate of improvement in the outcomes of the studies may have greatly differed.

Figures

Figure 1
Figure 1
Flow chart. Search and selection criteria conducted in accordance with PRISMA statement criteria. (Preferred Reporting Items for Systematic Reviews and Meta-Analyses).

References

    1. Greene R, Dalton K. The premenstrual syndrome. Br Med J. 1953;9:1007–1014.
    1. Pearlstein T, Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci. 2008;33:291–301.
    1. O’Brien PM. Helping women with premenstrual syndrome. Br Med J. 1993;307:1471–1475. doi: 10.1136/bmj.307.6917.1471.
    1. DeMonico SO, Brown CS, Ling FW. Premenstrual syndrome. Curr Opin Obstet Gynecol. 1994;6:499–502.
    1. Choi DS. Premenstrual syndrome. J Women Med. 2009;2(4):141–146.
    1. Kim SY, Park HJ, Lee H. Acupuncture for premenstrual syndrome: a systematic review and meta-analysis of randomized controlled trials. BJOG. 2011;118:899–915. doi: 10.1111/j.1471-0528.2011.02994.x.
    1. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement criteria .
    1. Chou PB, Morse CA, Xu H. A controlled trial of Chinese herbal medicine for premenstrual syndrome. J Psychosom Obstet Gynaecol. 2008;29(3):185–192.
    1. Kim SC, Kim SN, Lim JA, Choi CM, Shim EK, Koo ST, Ha JY, Sing KR, Sohn IC. Effects of acupuncture treatment on the premenstrual syndrome: controlled clinical trial. J Korean A&M Soc. 2005;22(1):41–60.
    1. Habek D, Habek JČ, Barbir A. Using acupuncture to treat premenstrual syndrome. Arch Gynecol Obstet. 2002;267:23–26. doi: 10.1007/s00404-001-0270-7.
    1. Shin KR, Young HJ, Park HJ, Heitkemper M. The effect of hand acupuncture therapy and hand moxibustion therapy on premenstrual syndrome among Korean women. West J Nurs Res. 2009;31(2):171–186.
    1. Xu Y. Clinical Study on the Treatment of Acupuncture of Back-Shu on Premenstrual Syndrome. Harbin: Heilongjiang University of Chinese Medicine; 2006. pp. 1–33.
    1. Xu Y, Sun Y. Observation of therapeutic effect of point-through point acupuncture method in the back on premenstrual syndrome. J Clin Acupunct Moxibust. 2006;22:37–38.
    1. Guo S, Sun Y. Comparison between acupuncture and medication in treatment of premenstrual syndrome. Shanghai J Acupunct Moxibust. 2004;23:5–6.
    1. Hong Y. Clinical therapeutic effect of scalp acupuncture on premenstrual tension syndrome. Chin Acupunct Moxibust. 2002;22(9):597–598.
    1. Yu J. Preliminary observation based on a systematic review of efficacy and safety of acupuncture treatment for premenstrual syndrome. Acupunct Dep. 2006. pp. 1–89.
    1. Ma L. Evaluating therapeutic effect in symptoms of moderate to severe premenstrual syndrome with Vitex Agnus castus (BNO 1095) in Chinese women. Aust N Z J Obstet Gynecol. 2010;50:189–193. doi: 10.1111/j.1479-828X.2010.01137.x.
    1. He Z, Chen R, Zhou Y, Geng L, Zhang Z, Chen S, Yao Y, Lu J, Lin S. Treatment for premenstrual syndrome with Vitex Agnus castus: a prospective, randomized, multicenter placebo controlled study in China. Maturitas. 2009;63(1):99–103. doi: 10.1016/j.maturitas.2009.01.006.
    1. Atmaca M, Selahattin K, Ertan T. Fluoxetine versus Vitex Agnus castus extract in the treatment of premenstrual dysphoric disorder. Human Psychopharmacol. 2003;18:191–195. doi: 10.1002/hup.470.
    1. Zamani M, Nosrat N, Saadat T. Therapeutic effect of Vitex Agnus castus in patients with premenstrual syndrome. Acta Med Iran. 2012;50(2):101–106.
    1. Canning S, Waterman M, Orsi N, Ayres J, Simpson N, Dye L. The efficacy of Hypericum perforatum (St John’s wart) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial. CNS Drugs. 2010;24(3):207–225. doi: 10.2165/11530120-000000000-00000.
    1. Hicks SM, Walker AF, Gallagher J, Middleton RW, Wright J. The significance of “nonsignificance” in randomized controlled studies: a discussion inspired by a double-blinded study on St. John’s wart (Hypericum perforatum L.) for premenstrual symptoms. J Altern Complement Med. 2004;10(6):925–932. doi: 10.1089/acm.2004.10.925.
    1. Masumeh G, Masumeh K, Nasrin A, Fariborz G, Samaneh Z, Hamid RT, Maryam D. Hypericum perforatum for the treatment of premenstrual syndrome. Int Fed Gynecol Obstet. 2010;11:7.
    1. Agha-Hosseini M, Kashani L, Aleyaseen A, Ghoreishi A, Rahmanpour H, Zarrinara AR, Akhondzadeh S. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomized and placebo controlled trial. BJOG. 2008;115:515–519. doi: 10.1111/j.1471-0528.2007.01652.x.
    1. Chung MS, Kim GH. Effects of Elsholtzia splendens and Cirsium japonicum on premenstrual syndrome. Nutr Res Pract. 2010;4(4):290–294. doi: 10.4162/nrp.2010.4.4.290.
    1. Ozgoli G, Selselei EA, Mojab F, Majd HA. A randomized, placebo controlled trial of Ginkgo biloba L. in treatment of premenstrual syndrome. J Altern Complement Med. 2009;15(8):845–851. doi: 10.1089/acm.2008.0493.
    1. van Die MD, Burger HG, Teede HJ, Bone KM. Vitex agnus-castus extracts for female reproductive. Disorders: a systematic review of clinical trials. Planta Med. 2013;79:562–575.
    1. Cho SH, Kim J. Efficacy of acupuncture in management of premenstrual syndrome: a systematic review. Complement Ther Med. 2010;18(2):104–111. doi: 10.1016/j.ctim.2009.12.001.
    1. Dante G, Facchinetti F. Herbal treatments for alleviating premenstrual symptoms: a systematic review. J Psychosom Obstet Gynaecol. 2011;32(1):42–51. doi: 10.3109/0167482X.2010.538102.
    1. Wood SH, Mortola JF, Chan YF, Moossazadeh F, Yen SSC. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study. Obstet Gynecol. 1992;80:339–344.
    1. Diegoli MSC, Fonseca AM, Diegoli CA, Pinotti JA. A double-blind trial of four medications to treat severe premenstrual syndrome. Int J Gynecol Obstet. 1998;62:63–67. doi: 10.1016/S0020-7292(98)00035-6.
    1. Yang YQ, Huang GY. Study on effects of acupuncture on mice dysmenorrheal model and the mechanism. Zhongguo Zhen Jiu. 2008;28:119–121.
    1. Zhou J, Qu F. Treating gynecological disorders with traditional chin medicine: a review. Afr J Tradit Complement Altern Med. 2009;6(4):500–501.
    1. Singh BB, Berman BM, Simpson RL. Incidence of premenstrual syndrome and remedy usage: a national probability sample study. Altern Ther Health Med. 1998;4(3):75–79.
    1. Hardy ML. Herbs of special interest to women. J Am Pharm Assoc. 2000;40(2):234–242.
    1. Calapai G, Crupi A, Firenzuoli F, Inferrera G, Squadrito F, Parisi A, De Sarro G, Caputi A. Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum. Pharmacopsychiatry. 2001;34(2):45–49. doi: 10.1055/s-2001-15180.
    1. Duvan CI, Cumaoglu A, Turhan NO, Karasu C, Kafali H. Oxidant/antioxidant status in premenstrual syndrome. Arch Gynecol Obstet. 2011;283:299–304. doi: 10.1007/s00404-009-1347-y.
    1. Youn JS. Comparison study on the beneficial effect of Elsholtzia splendens and Elsholtzia ciliate. J Herbol. 1992;7:33–45.
    1. Zou Y, Lu Y, Wei D. Antioxidant activity of a Flavonoid-Rich Extract of Hypericum perforatum L. in Vitro. J Agric Food Chem. 2004;52(16):5032–5039. doi: 10.1021/jf049571r.
    1. McKenna DJ, Jones K, Hughes K. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. Altern Ther Health Med. 2001;7(5):70–86.
    1. Tamborini A, Taurelle R. Value of standardized Ginkgo biloba extract (EGb 761) in the management of congestive symptoms of premenstrual syndrome. Rev Fr Gynecol Obstet. 1993;88(4):47–57.
    1. Clark H, Wells G, Huët C, McAlister F, Salmi R, Fergusson D, Laupacis A. Assessing the quality of randomized trials: reliability of the jadad scale. Control Clin Trials. 1999;20(5):448–452. doi: 10.1016/S0197-2456(99)00026-4.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere